We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
DuPont (DD) Unit Expands Phytase Product Line in Europe
Read MoreHide Full Article
DuPont’s (DD - Free Report) Industrial Biosciences unit has launched Axtra PHY 20000 TPT and Axtra PHY 25000 G in Europe, thereby expanding the product line of its award-winning phytase in the European Union (EU). The fastest-acting phytase enzyme is now available in every desired format to all European animal producers.
Proven to be the most efficacious phytase available in the market today, Axtra PHY has been helping animal producers to reduce their production costs as well as their environmental footprint.
The product starts acting earlier in the digestive tract and destroys phytate and its anti-nutrient effects rapidly. This enables more nutrient uptake in the animal. Axtra PHY enables the release and digestion of beneficial nutrients naturally present in the feed by lowering the impact of phytate. As a result the animal producer can significantly lower their feed cost.
In addition to this, Axtra PHY at 1000 FTU (phytase units) can breakdown more than 90% of dietary phytate and decrease feed conversion ratio by up to 10%.
DuPont has outperformed the Zacks categorized Chemicals-Diversified industry over a year. The company’s shares have rallied 29.3% over this period, compared with the industry’s gain of around 25.8%.
DuPont is well placed to gain from its cost-cutting measures and new product launches. It has numerous new products in its pipeline that should contribute to the top-line growth.
Moreover, the proposed mega-merger with Dow Chemical (DOW - Free Report) is expected to deliver cost synergies of around $3 billion. The companies recently secured the U.S. antitrust clearance for the planned merger and expect the closing of the deal to take place in Aug 2017.
E.I. du Pont de Nemours and Company Price and Consensus
Just released, today's 220 Zacks Rank #5 Strong Sells demand urgent attention. If any are lurking in your portfolio or Watch List, they should be removed immediately. These are sinister companies because many appear to be sound investments. However, from 1988 through 2016, stocks from our Strong Sell list have actually performed 6X worse than the S&P 500.
Image: Bigstock
DuPont (DD) Unit Expands Phytase Product Line in Europe
E.I. du Pont de Nemours and Company Price and Consensus | E.I. du Pont de Nemours and Company Quote